Orange Book product · Brand (NDA)
NAMENDA
MEMANTINE HYDROCHLORIDE
At a glance
Oct 16, 2003
Approved
Brand (NDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Oct 16, 2003
23 yr ago
Today
Pharmaceutical detail
Active ingredient
MEMANTINE HYDROCHLORIDE
Strength
5MG
Dosage form
TABLET
Route
ORAL
TE code
Not listed
Application
NDA 021487
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2010NAMENDA XRBrand (NDA)
NDA 022525 · ABBVIE
- 2005NAMENDABrand (NDA)
NDA 021627 · ALLERGAN
- 2025MEMANTINE HYDROCHLORIDEGeneric (ANDA)
ANDA 206310 · MACLEODS PHARMS LTD
- 2022MEMANTINE HYDROCHLORIDEGeneric (ANDA)
ANDA 213985 · VITRUVIAS
- 2022MEMANTINE HYDROCHLORIDEGeneric (ANDA)
ANDA 204389 · HETERO LABS LTD V
- 2021MEMANTINE HYDROCHLORIDEGeneric (ANDA)
ANDA 214651 · AUROBINDO PHARMA LTD
- 2021MEMANTINE HYDROCHLORIDEGeneric (ANDA)
ANDA 211100 · YICHANG HUMANWELL
- 2020MEMANTINE HYDROCHLORIDEGeneric (ANDA)
ANDA 210587 · PURACAP LABS BLU
- 2020MEMANTINE HYDROCHLORIDEGeneric (ANDA)
ANDA 210319 · MEDLEY PHARMS
- 2020MEMANTINE HYDROCHLORIDEGeneric (ANDA)
ANDA 212947 · YILING
- 2020MEMANTINE HYDROCHLORIDEGeneric (ANDA)
ANDA 205365 · ANI PHARMS
- 2020MEMANTINE HYDROCHLORIDEGeneric (ANDA)
ANDA 208173 · HIKMA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

